Type of securities : Common share | Effective Date : 13/02/2024 | Close Selling Date : 16/02/2024

ประเภทหลักทรัพย์ : หุ้นสามัญ | วันที่มีผลใช้บังคับ : 13/02/2567 | วันที่ปิดการขาย : 16/02/2567

Audit Committee of the Company All 7 members of the Board of Directors, including the Audit Committee, are of the view that the entering into this transaction is reasonable. Apart from increasing strength

Committee and/or Director of the Company that different from the Board of Directors opinion; The Company convened Audit Committee’s Meeting No.3/2017 on 11 August 2017 in order to consider such transaction

derived from the expansion of medical and excellence center, the enhanced ability as well as the acquisition of high-growth potential hospital(s). 8. Opinion of the Board of Directors The Board of Directors

shall include the following details: 7.3.1 Information on each appointed subcommittee. For example, the Audit Committee, the Executive Board of Directors, the Risk Management Committee, the Selection

governance structure and material facts related to the board, 23 subcommittees, executives, employees and others 8. Report on key operating results related to corporate governance 28 9. Internal control and

the Company or the group of companies, as specified by the Board of Directors (if any), to be used as guidelines for investors to understand and monitor future business directions of the Company. 1.2

directors and executives such as fixed or variable remunerations, etc., including the opinions of the Board of Directors or the Remuneration Sub-committee (if any) whether such structure is appropriate for

2 PPAs with EGAT of which qualified for the PPA extension and replacement for another 25-year period according to the outcomes of the National Energy Policy Committee’s Meeting on 24 January 2019